10 min read
The rise of the AI-empowered patient: How direct-to-patient models will rewrite pharma commercialization
James Lewis: May 5, 2026 5:56:53 PM
AI tools, at-home diagnostics, and new DTP platforms—from LillyDirect and PfizerForAll, to TrumpRx and Cost Plus Drugs—are turning patients into...